Lepercq De Neuflize Asset Management’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,234
Closed -$31.6K 10
2025
Q1
$31.6K Buy
+23,234
New +$31.6K 0.03% 10